[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Mesenchymal Stem Cell Market Report 2016

November 2016 | 113 pages | ID: UB9A8166202EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Mesenchymal Stem Cell

Revenue, means the sales value of Mesenchymal Stem Cell

Revenue, means the salies sales (consumption) of Mesenchymal Stem Cell in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Biomet, Inc. (US)
  • Bioventus LLC (US)
  • DePuy Synthes Companies (US)
  • DePuy Spine, Inc. (US)
  • Exactech, Inc. (US)
  • Histogenics Corp. (US)
  • Integra LifeSciences Holdings Corp (US)
  • LifeCell Corporation (US)
  • LifeNet Health, Inc. (US)
  • Medtronic, Inc. (US)
  • NovaBone Products LLC (US)
  • NuVasive, Inc. (US)
  • Orthofix International N.V. (Netherlands)
  • Osiris Therapeutics, Inc. (US)
  • Smith & Nephew Plc (UK)
  • Stryker Corporation (US)
  • TiGenix N.V. (Belgium)
  • Wright Medical Technology, Inc. (US)
  • BioMimetic Therapeutics LLC (US)
  • Zimmer Holdings, Inc. (US)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Mesenchymal Stem Cell in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Mesenchymal Stem Cell Market Report 2016

1 MESENCHYMAL STEM CELL OVERVIEW

1.1 Product Overview and Scope of Mesenchymal Stem Cell
1.2 Classification of Mesenchymal Stem Cell
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Mesenchymal Stem Cell
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Mesenchymal Stem Cell (2011-2021)
  1.4.1 United States Mesenchymal Stem Cell Sales and Growth Rate (2011-2021)
  1.4.2 United States Mesenchymal Stem Cell Revenue and Growth Rate (2011-2021)

2 UNITED STATES MESENCHYMAL STEM CELL COMPETITION BY MANUFACTURERS

2.1 United States Mesenchymal Stem Cell Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Mesenchymal Stem Cell Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Mesenchymal Stem Cell Average Price by Manufactures (2015 and 2016)
2.4 Mesenchymal Stem Cell Market Competitive Situation and Trends
  2.4.1 Mesenchymal Stem Cell Market Concentration Rate
  2.4.2 Mesenchymal Stem Cell Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MESENCHYMAL STEM CELL SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Mesenchymal Stem Cell Sales and Market Share by Type (2011-2016)
3.2 United States Mesenchymal Stem Cell Revenue and Market Share by Type (2011-2016)
3.3 United States Mesenchymal Stem Cell Price by Type (2011-2016)
3.4 United States Mesenchymal Stem Cell Sales Growth Rate by Type (2011-2016)

4 UNITED STATES MESENCHYMAL STEM CELL SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Mesenchymal Stem Cell Sales and Market Share by Application (2011-2016)
4.2 United States Mesenchymal Stem Cell Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES MESENCHYMAL STEM CELL MANUFACTURERS PROFILES/ANALYSIS

5.1 Biomet, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Mesenchymal Stem Cell Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Biomet, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bioventus LLC (US)
  5.2.2 Mesenchymal Stem Cell Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bioventus LLC (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 DePuy Synthes Companies (US)
  5.3.2 Mesenchymal Stem Cell Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 DePuy Synthes Companies (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 DePuy Spine, Inc. (US)
  5.4.2 Mesenchymal Stem Cell Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 DePuy Spine, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Exactech, Inc. (US)
  5.5.2 Mesenchymal Stem Cell Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Exactech, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Histogenics Corp. (US)
  5.6.2 Mesenchymal Stem Cell Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Histogenics Corp. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Integra LifeSciences Holdings Corp (US)
  5.7.2 Mesenchymal Stem Cell Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Integra LifeSciences Holdings Corp (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 LifeCell Corporation (US)
  5.8.2 Mesenchymal Stem Cell Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 LifeCell Corporation (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 LifeNet Health, Inc. (US)
  5.9.2 Mesenchymal Stem Cell Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 LifeNet Health, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Medtronic, Inc. (US)
  5.10.2 Mesenchymal Stem Cell Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Medtronic, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 NovaBone Products LLC (US)
5.12 NuVasive, Inc. (US)
5.13 Orthofix International N.V. (Netherlands)
5.14 Osiris Therapeutics, Inc. (US)
5.15 Smith & Nephew Plc (UK)
5.16 Stryker Corporation (US)
5.17 TiGenix N.V. (Belgium)
5.18 Wright Medical Technology, Inc. (US)
5.19 BioMimetic Therapeutics LLC (US)
5.20 Zimmer Holdings, Inc. (US)

6 MESENCHYMAL STEM CELL MANUFACTURING COST ANALYSIS

6.1 Mesenchymal Stem Cell Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Mesenchymal Stem Cell

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Mesenchymal Stem Cell Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Mesenchymal Stem Cell Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES MESENCHYMAL STEM CELL MARKET FORECAST (2016-2021)

10.1 United States Mesenchymal Stem Cell Sales, Revenue Forecast (2016-2021)
10.2 United States Mesenchymal Stem Cell Sales Forecast by Type (2016-2021)
10.3 United States Mesenchymal Stem Cell Sales Forecast by Application (2016-2021)
10.4 Mesenchymal Stem Cell Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Mesenchymal Stem Cell
Table Classification of Mesenchymal Stem Cell
Figure United States Sales Market Share of Mesenchymal Stem Cell by Type in 2015
Table Application of Mesenchymal Stem Cell
Figure United States Sales Market Share of Mesenchymal Stem Cell by Application in 2015
Figure United States Mesenchymal Stem Cell Sales and Growth Rate (2011-2021)
Figure United States Mesenchymal Stem Cell Revenue and Growth Rate (2011-2021)
Table United States Mesenchymal Stem Cell Sales of Key Manufacturers (2015 and 2016)
Table United States Mesenchymal Stem Cell Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Mesenchymal Stem Cell Sales Share by Manufacturers
Figure 2016 Mesenchymal Stem Cell Sales Share by Manufacturers
Table United States Mesenchymal Stem Cell Revenue by Manufacturers (2015 and 2016)
Table United States Mesenchymal Stem Cell Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Mesenchymal Stem Cell Revenue Share by Manufacturers
Table 2016 United States Mesenchymal Stem Cell Revenue Share by Manufacturers
Table United States Market Mesenchymal Stem Cell Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Mesenchymal Stem Cell Average Price of Key Manufacturers in 2015
Figure Mesenchymal Stem Cell Market Share of Top 3 Manufacturers
Figure Mesenchymal Stem Cell Market Share of Top 5 Manufacturers
Table United States Mesenchymal Stem Cell Sales by Type (2011-2016)
Table United States Mesenchymal Stem Cell Sales Share by Type (2011-2016)
Figure United States Mesenchymal Stem Cell Sales Market Share by Type in 2015
Table United States Mesenchymal Stem Cell Revenue and Market Share by Type (2011-2016)
Table United States Mesenchymal Stem Cell Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Mesenchymal Stem Cell by Type (2011-2016)
Table United States Mesenchymal Stem Cell Price by Type (2011-2016)
Figure United States Mesenchymal Stem Cell Sales Growth Rate by Type (2011-2016)
Table United States Mesenchymal Stem Cell Sales by Application (2011-2016)
Table United States Mesenchymal Stem Cell Sales Market Share by Application (2011-2016)
Figure United States Mesenchymal Stem Cell Sales Market Share by Application in 2015
Table United States Mesenchymal Stem Cell Sales Growth Rate by Application (2011-2016)
Figure United States Mesenchymal Stem Cell Sales Growth Rate by Application (2011-2016)
Table Biomet, Inc. (US) Basic Information List
Table Biomet, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biomet, Inc. (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table Bioventus LLC (US) Basic Information List
Table Bioventus LLC (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bioventus LLC (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table DePuy Synthes Companies (US) Basic Information List
Table DePuy Synthes Companies (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table DePuy Synthes Companies (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table DePuy Spine, Inc. (US) Basic Information List
Table DePuy Spine, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table DePuy Spine, Inc. (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table Exactech, Inc. (US) Basic Information List
Table Exactech, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table Exactech, Inc. (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table Histogenics Corp. (US) Basic Information List
Table Histogenics Corp. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table Histogenics Corp. (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table Integra LifeSciences Holdings Corp (US) Basic Information List
Table Integra LifeSciences Holdings Corp (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table Integra LifeSciences Holdings Corp (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table LifeCell Corporation (US) Basic Information List
Table LifeCell Corporation (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table LifeCell Corporation (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table LifeNet Health, Inc. (US) Basic Information List
Table LifeNet Health, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table LifeNet Health, Inc. (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table Medtronic, Inc. (US) Basic Information List
Table Medtronic, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medtronic, Inc. (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table NovaBone Products LLC (US) Basic Information List
Table NovaBone Products LLC (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table NovaBone Products LLC (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table NuVasive, Inc. (US) Basic Information List
Table NuVasive, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table NuVasive, Inc. (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table Orthofix International N.V. (Netherlands) Basic Information List
Table Orthofix International N.V. (Netherlands) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orthofix International N.V. (Netherlands) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table Osiris Therapeutics, Inc. (US) Basic Information List
Table Osiris Therapeutics, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table Osiris Therapeutics, Inc. (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table Smith & Nephew Plc (UK) Basic Information List
Table Smith & Nephew Plc (UK) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table Smith & Nephew Plc (UK) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table Stryker Corporation (US) Basic Information List
Table Stryker Corporation (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table Stryker Corporation (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table TiGenix N.V. (Belgium) Basic Information List
Table TiGenix N.V. (Belgium) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table TiGenix N.V. (Belgium) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table Wright Medical Technology, Inc. (US) Basic Information List
Table Wright Medical Technology, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wright Medical Technology, Inc. (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table BioMimetic Therapeutics LLC (US) Basic Information List
Table BioMimetic Therapeutics LLC (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioMimetic Therapeutics LLC (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table Zimmer Holdings, Inc. (US) Basic Information List
Table Zimmer Holdings, Inc. (US) Mesenchymal Stem Cell Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zimmer Holdings, Inc. (US) Mesenchymal Stem Cell Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Mesenchymal Stem Cell
Figure Manufacturing Process Analysis of Mesenchymal Stem Cell
Figure Mesenchymal Stem Cell Industrial Chain Analysis
Table Raw Materials Sources of Mesenchymal Stem Cell Major Manufacturers in 2015
Table Major Buyers of Mesenchymal Stem Cell
Table Distributors/Traders List
Figure United States Mesenchymal Stem Cell Production and Growth Rate Forecast (2016-2021)
Figure United States Mesenchymal Stem Cell Revenue and Growth Rate Forecast (2016-2021)
Table United States Mesenchymal Stem Cell Production Forecast by Type (2016-2021)
Table United States Mesenchymal Stem Cell Consumption Forecast by Application (2016-2021)


More Publications